| Original language | English |
|---|---|
| Pages (from-to) | 234-242 |
| Number of pages | 9 |
| Journal | Oncotarget |
| Volume | 6 |
| Issue number | 1 |
| Publication status | Published - 2015 |
| Externally published | Yes |
Cite this
Bishop, J. L., Sio, A., Angeles, A., Roberts, M. E., Azad, A. A., Chi, K. N., & Zoubeidi, A. (2015). PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. Oncotarget, 6(1), 234-242.
@article{6079499245c84bcaafa8f78ce84e507e,
title = "PD-L1 is highly expressed in Enzalutamide resistant prostate cancer",
author = "Bishop, {Jennifer L} and Alexander Sio and Arkhjamil Angeles and Roberts, {Morgan E} and Azad, {Arun A} and Chi, {Kim N} and Amina Zoubeidi",
year = "2015",
language = "English",
volume = "6",
pages = "234--242",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "1",
}
Bishop, JL, Sio, A, Angeles, A, Roberts, ME, Azad, AA, Chi, KN & Zoubeidi, A 2015, 'PD-L1 is highly expressed in Enzalutamide resistant prostate cancer', Oncotarget, vol. 6, no. 1, pp. 234-242.
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. / Bishop, Jennifer L; Sio, Alexander; Angeles, Arkhjamil; Roberts, Morgan E; Azad, Arun A; Chi, Kim N; Zoubeidi, Amina.
In: Oncotarget, Vol. 6, No. 1, 2015, p. 234-242.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
AU - Bishop, Jennifer L
AU - Sio, Alexander
AU - Angeles, Arkhjamil
AU - Roberts, Morgan E
AU - Azad, Arun A
AU - Chi, Kim N
AU - Zoubeidi, Amina
PY - 2015
Y1 - 2015
M3 - Article
VL - 6
SP - 234
EP - 242
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 1
ER -
Bishop JL, Sio A, Angeles A, Roberts ME, Azad AA, Chi KN et al. PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. Oncotarget. 2015;6(1):234-242.